SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VaxGen Inc.-The 1st AIDS Vaccine in Phase 3 HumanTrials -- Ignore unavailable to you. Want to Upgrade?


To: scion who wrote (184)1/21/2003 12:18:40 AM
From: scion  Respond to of 250
 
LAST 10 INSIDER ACTIONS

Date Name Shares Transaction

12/13/02 VULCAN VENTURES INC
Shareholder 252,210 Proposed Sale (Form 144)
estimated proceeds of $3,281,252.10

12/11/02 VULCAN VENTURES INC
Shareholder 100,000 Proposed Sale (Form 144)
estimated proceeds of $1,687,000.00

12/4/02 VULCAN VENTURES INC
Shareholder 100,000 Proposed Sale (Form 144)
estimated proceeds of $1,835,000.00

11/22/02 VULCAN VENTURES INC
Shareholder 150,000 Proposed Sale (Form 144)
estimated proceeds of $2,697,000.00

11/20/02 VULCAN VENTURES INC
Shareholder 280,000 Proposed Sale (Form 144)
estimated proceeds of $4,656,400.00

11/20/02 PAUL G ALLEN
Beneficial Owner of more than 10% of a Class of Security 319,100 Open Market Sale
proceeds of $5,340,138.50

11/19/02 PAUL G ALLEN
Beneficial Owner of more than 10% of a Class of Security 350,000 Open Market Sale
proceeds of $6,128,395.00

11/19/02 VULCAN VENTURES INC
Shareholder 350,000 Proposed Sale (Form 144)
estimated proceeds of $5,572,000.00

11/18/02 VULCAN VENTURES INC
Shareholder 150,000 Proposed Sale (Form 144)
estimated proceeds of $2,940,000.00

11/18/02 PAUL G ALLEN
Beneficial Owner of more than 10% of a Class of Security 110,900 Open Market Sale
proceeds of $2,392,667.50

marketwatch.nytimes.com